HEPATITIS B VACCINE;
INACTIVATED VACCINE;
MEASLES VACCINE;
ORAL POLIOMYELITIS VACCINE;
ANTIBODY TITER;
DRUG EFFICACY;
DRUG MARKETING;
ENDEMIC DISEASE;
HEALTH CARE POLICY;
HEALTH PROGRAM;
HEPATITIS B;
HUMAN;
INDIA;
MEASLES;
POLIOMYELITIS;
REVIEW;
VACCINATION;
VACCINE FAILURE;
VIRUS IMMUNITY;
Vaccine associated paralytic poliomyelitis (VAPP) in India is jeopardizing the goal of regional and global eradication of polio
Mathew JL. Vaccine associated paralytic poliomyelitis (VAPP) in India is jeopardizing the goal of regional and global eradication of polio. Int J Infect Dis 2006; 10 Suppl1: S221-S222
Vaccine-associated paralytic poliomyelitis in India during 1999: Decreased risk despite massive use of oral polio vaccine
Kohler KA, Banerjee K, Hlady WG, Andrus JK, Sutter RW. Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine. Bull WHO 2002; 80: 210-216.
Polio eradication strategies in India: Recommendations under IAP Action Plan 2006
Shah NK, John TJ, Thacker N, Vashistha V, Kalra A, Ugra D. Polio eradication strategies in India: Recommendations under IAP Action Plan 2006. Indian Pediatr 2006; 43: 1057-1063.
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine
Moriniere BJ, van Loon FP, Rhodes PH, Klein-Zabban ML, Frank-Senat B, Herrington JE, et al. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet 1993; 341: 1545-1550.
Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States
Sutter RW, Prevots DR, Cochi SL. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States. Pediatr Clin North Am 2000; 47: 287-302.
